Economic costs for the production of health services: From cost of inputs to cost of case-management;Costos economicos en la produccion de servicios de salud: Del costo de los insumos al costo de manejo de caso

Salud Publica de Mexico

Volumn 39, Issue 2, 1997, Pages 117-124

  Arredondo, Armando ^a   Damián, Teresa ^a  

^a INSTITUTO NACIONAL DE SALUD PÚBLICA   (Mexico)

Author keywords

costs and cost analysis; health services; Mexico

Indexed keywords

ARTICLE; CONTROLLED STUDY; COST; COST BENEFIT ANALYSIS; HEALTH CARE ORGANIZATION; HEALTH SERVICE; MEXICO; ADULT; AMBULATORY CARE; CASE MANAGEMENT; CHILD; DIABETES MELLITUS; DIARRHEA; ECONOMICS; HOSPITAL COST; HUMAN; HYPERTENSION; METHODOLOGY; PNEUMONIA;

ADULT; AMBULATORY CARE; CASE MANAGEMENT; CHILD; COSTS AND COST ANALYSIS; DIABETES MELLITUS; DIARRHEA; HEALTH SERVICES; HEALTH SERVICES NEEDS AND DEMAND; HOSPITAL COSTS; HUMANS; HYPERTENSION; MEXICO; PNEUMONIA;

EID: 0030992324     PISSN: 00363634     EISSN: None     Source Type: Journal    
DOI: 10.1590/s0036-36341997000200005     Document Type: Article

References (11)

1. Hernández P, Arredondo A, Ortiz C, Rosenthal G. Avances y retos de la economía de la salud. Rev Saude Publica 1995;29(4):326-332.
2. Frenk J, Ruelas E, Bobadilla JL, Zurita B, Lozano R, Cruz C et al. Economía y salud: propuestas para el avance del sistema de salud en México: vision de conjunto. México, D.F.: Fundación Mexicana para la Salud, 1994.
3. Jamison D, Mosley H. Disease control priorities in developing countries: Health policy responses to epidemiological change. Am J Public Health 1991:81(1)15-22.
4. Mills A, Gilson L. Health economics for developing countries: A survival kit. Londres: EPC, 1988,(17):59-71.
5. Musgrove P. The economic crisis and its impact on health and health care in Latin America. Int J Health Serv 1987;17(3):411-421.
6. Sistema Nacional de Evaluación-Programa Nacional deAcción. Secretaría de Salud, instituto Mexicano del Seguro Social, Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado. Informe de seguimiento y evaluación 1990-1992. México, D.F.: Sistema Nacional de Evaluación, 1992:36-63.
7. Kessner D, Kalk C, Singer J. Assesing health-the case for tracers. N Engl J Med 1973;288(4):189-194.
8. Arredondo A, De Icaza E, Locket L. Cost of four tracer diseases in Brasil: Cardiac valve disease, bronchopneumonia, diarrhea and breast cancer. Rev Saude Publics 1995;29(5):349-354.
9. Bobadilla JL, Cowley P, Musgroe P, Saxenian H. Design, content and financing of an essential national package of health services. Bull World Health Organ 1994;72(4):284-293.
10. Fisher S, Dornbusch R, Schmalensee R. Economia: métodos de depreciación. 2a. edición. Massachusetts, Instituto Tecnológico de Massachusetts. Boston: McGraw-Hill, 1990:418-422
11. Jamison D, Mosley W, Measham A, Bobadilla JL. Disease control priorities for developing countries. Washington, D.C.: Oxford University Press, World Bank, 1993:91-117.